Antibioprophylaxie des infections urinaires récidivantes (chez la femme non enceinte): pour ou contre ? : INFECTIONS URINAIRES = Antimicrobial prophylaxis for preventing recurrent urinary tract infections in non-pregnant women: pros and cons. : URINARY TRACT INFECTIONSRENVOISE, Aurélie; BAGNIS, Corinne Isnard; AUBRY, Alexandra et al.La Revue du praticien (Paris). 2014, Vol 64, Num 7, pp 972-973, issn 0035-2640, 2 p.Article

Contribution of the ATP binding site of ParE to susceptibility to novobiocin and quinolones in Streptococcus pneumoniaeDUPONT, Philippe; AUBRY, Alexandra; CAMBAU, Emmanuelle et al.Journal of bacteriology. 2005, Vol 187, Num 4, pp 1536-1540, issn 0021-9193, 5 p.Article

Argumentation sur la durée des traitements antituberculeux : Tuberculose = Trends in tuberculosis treatment durationVEZIRIS, Nicolas; AUBRY, Alexandra; TRUFFOT-PERNOT, Chantai et al.La Presse médicale (1983). 2006, Vol 35, Num 11, pp 1758-1764, issn 0755-4982, 7 p., CAH2Article

Are All the DNA Gyrase Mutations Found in Mycobacterium leprae Clinical Strains Involved in Resistance to Fluoroquinolones?MATRAT, Stéphanie; CAMBAU, Emmanuelle; JARLIER, Vincent et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 2, pp 745-747, issn 0066-4804, 3 p.Article

Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex IsolatesBROSSIER, Florence; VEZIRIS, Nicolas; AUBRY, Alexandra et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 5, pp 1683-1689, issn 0095-1137, 7 p.Article

Mutagenesis in the a3a4 GyrA Helix and in the Toprim Domain of GyrB Refines the Contribution of Mycobacterium tuberculosis DNA Gyrase to Intrinsic Resistance to QuinolonesMATRAT, Stéphanie; AUBRY, Alexandra; MAYER, Claudine et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 8, pp 2909-2914, issn 0066-4804, 6 p.Article

Sixty-three cases of Mycobacterium marinum infection: Clinical features, treatment, and antibiotic susceptibility of causative isolatesAUBRY, Alexandra; CHOSIDOW, Olivier; CAUMES, Eric et al.Archives of internal medicine (1960). 2002, Vol 162, Num 15, pp 1746-1752, issn 0003-9926Article

Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumanniiQIN LU; RUBIN LUO; BODIN, Liliane et al.Anesthesiology (Philadelphia). 2012, Vol 117, Num 6, pp 1335-1347, issn 0003-3022, 13 p.Article

Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolonesMATRAT, Stéphanie; PETRELLA, Stéphanie; CAMBAU, Emmanuelle et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 5, pp 1643-1648, issn 0066-4804, 6 p.Article

Impacts of Dosing Frequency of the Combination Rifampin-Streptomycin on Its Bactericidal and Sterilizing Activities against Mycobacterium ulcerans in MiceBAOHONG JI; CHAUFFOUR, Aurélie; AUBRY, Alexandra et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 7, pp 2955-2959, issn 0066-4804, 5 p.Article

Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coliCAMBAU, Emmanuelle; MATRAT, Stephanie; PAN, Xiao-Su et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 3, pp 443-450, issn 0305-7453, 8 p.Article

Mycobacterium tuberculosis DNA gyrase: Interaction with quinolones and correlation with antimycobacterial drug activityAUBRY, Alexandra; PAN, Xiao-Su; FISHER, L. Mark et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 1281-1288, issn 0066-4804, 8 p.Article

Imipenem, Meropenem, or Doripenem To Treat Patients with Pseudomonas aeruginosa Ventilator-Associated PneumoniaLUYT, Charles-Edouard; AUBRY, Alexandra; JARLIER, Vincent et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 3, pp 1372-1380, issn 0066-4804, 9 p.Article

Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the a subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolonesMATRAT, Stéphanie; VEZIRIS, Nicolas; MAYER, Claudine et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 12, pp 4170-4173, issn 0066-4804, 4 p.Article

Impact of Fluoroquinolone Resistance on Bactericidal and Sterilizing Activity of a Moxifloxacin-Containing Regimen in Murine TuberculosisFILLION, Aurélie; AUBRY, Alexandra; BROSSIER, Florence et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 9, pp 4496-4500, issn 0066-4804, 5 p.Article

Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. tuberculosisPANTEL, Alix; PETRELLA, Stéphanie; VEZIRIS, Nicolas et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 4, pp 1990-1996, issn 0066-4804, 7 p.Article

Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine ModelPOISSY, Julien; AUBRY, Alexandra; FERNANDEZ, Christine et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 11, pp 4765-4771, issn 0066-4804, 7 p.Article

Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis : Functional analysis of mutant enzymesAUBRY, Alexandra; VEZIRIS, Nicolas; CAMBAU, Emmanuelle et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 1, pp 104-112, issn 0066-4804, 9 p.Article

Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivoVEZIRIS, Nicolas; TRUFFOT-PERNOT, Chantal; AUBRY, Alexandra et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 10, pp 3117-3122, issn 0066-4804, 6 p.Article